The company is developing a proteomic test for chronic obstructive pulmonary disease that it plans to launch in early 2018 as a CLIA-based diagnostic.
The researchers found that adding PBI's MicroPestle tool to a conventional pressure cycling workflow yielded between 20 and 40 percent more peptides.
Following similar work by Canadian researchers in E. coli, the study indicates interest in LC-MS/MS in clinical microbiology, which has been dominated by MALDI.
The firm said it has addressed the doublet issue for its C1 analyzer, and noted that it expects the bulk of revenue growth to come in the second half of the year.
The company reported revenues of $375.4 million, up from $353.5 million for the first quarter of 2015 and above analysts' consensus estimate of $360.2 million.
In Science this week: CRISPR-based approach to identify gene variants, and more.
Stat News profiles the Wellcome Trust's Jeremy Farrar.
France's research minister tells Nature News that he hopes to simplify the research bureaucracy and improve funding.
A recent study examines how a paper, despite being retracted, can influence its field, Retraction Watch reports.